|
|||||
|
|
||||||
Journal of Clinical Oncology, Vol 25, No 6 (February 20), 2007: pp. 735-a-736 © 2007 American Society of Clinical Oncology. DOI: 10.1200/JCO.2006.08.8443
Recommended Organ Preservation Strategy for T2 Unfavorable Glottis CancerAmrita Institute of Medical Sciences, Kochi, India To the Editor: The "American Society of Clinical Oncology Clinical Practice Guideline for the Use of Larynx-Preservation Strategies in the Treatment of Laryngeal Cancer" by Pfister et al1 is very useful in the management of laryngeal cancer. I would like to put forward the following query. The recommended organ preservation strategy in Table 1 of the article for unfavorable T2 cancer of glottis (a deeply invasive tumor on radiographic imaging, with or without subglottic extension, with impaired mobility, indicating deeper invasion) is open organ preservation surgery or concurrent chemoradiotherapy (in selected patients with node-positive disease). Kindly clarify the recommended strategy for T2 cancer of the glottis, unfavorable, without node positivity. Why is radiation therapy not recommended in this situation and put under other options onlyin the Table? Is concurrent chemoradiation recommended in this situation also? AUTHOR'S DISCLOSURES OF POTENTIAL CONFLICTS OF INTEREST The author indicated no potential conflicts of interest. REFERENCES
1. Pfister DG, Laurie SA, Weinstein GS, et al: American Society of Clinical Oncology clinical practice guideline for the use of larynx- preservation strategies in the treatment of laryngeal cancer. J Clin Oncol 24:3693-3704, 2006 Related Reply
Related Article
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||
|
Copyright © 2007 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
|